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Fig 2. Initial angiogram (A) revealing arterial supply to AVM (arrow).
Repeat angiogram (B) following placement of thoracic aortic stent graft
with coverage of T3 to T9 intercostal arteries (arrowheads) and coil
embolization of T10 intercostal artery (arrow) demonstrates reduced ﬂow
to the AVM.
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retrieval using formal decision analysis.
Methods: A Markov state-transition model was used to simulate two
clinical scenarios: to leave a previously placed IVC ﬁlter or to retrieve it.
Analysis was performed over the lifetime of the individual, and outcomes
were expressed in quality-adjusted life years (QALYs). The base case is a
60-year-old man with a ﬁlter placed within 3 months who no longer re-
quires mechanical thromboprophylaxis. Potential events included PE, ﬁlter
complications, and death from all other causes during each cycle. Tolls were
used to incorporate the disutility of short-term treatment for PE and/or ﬁl-
ter complications. For the base-case and sensitivity analyses, we used utilities
and probabilities derived from the literature.
Results: In the base-case scenario, leaving the ﬁlter in place was
preferred to ﬁlter retrieval, yielding 22.3 vs 21.9 QALYs. One-way sensi-
tivity analysis demonstrated that ﬁlter retrieval might be preferable if the
utility of living with a ﬁlter is <0.98. For all probabilities of retrieval and
PE mortality, leaving the ﬁlter in place is preferred.
Conclusions: Leaving a previously placed IVC ﬁlter provides a 0.4
QALY beneﬁt over retrieving the ﬁlter for the average patient. This decision
is sensitive to the utility of living with the IVC ﬁlter and underlying PE risk.
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Objectives: Cobb syndrome is a rare, nonfamilial, neurocutaneous
disorder characterized by spinal vascular abnormalities in association with
a vascular lesion of the skin at the same metamere (cutaneomeningospinal
angiomatosis). Patients are diagnosed at any age but most commonly in
late childhood and typically after the onset of neurologic symptoms, such
as paraplegia, quadriplegia, back pain, and, less commonly, fatigue due to
heart failure. Available treatment options to date have included neurosur-
gical resection and endovascular embolization. We present a case of a pro-
gressively symptomatic thoracic arteriovenous malformation (AVM) in a
patient with Cobb syndrome and demonstrate successful endovascular
thoracic stent graft placement and coil embolization.
Methods: A 37-year-old man presented with increasing symptoms of
high cardiac output and back pain. Computed tomography and magnetic
resonance imaging demonstrated a massive AVM involving the thoracic
vertebrae and left hemithorax, with extensive blood supply from the T3 to
T10 intercostal arteries and dilated azygous and hemiazygous venous struc-
tures (Fig 1). Soft tissue biopsy revealed diffuse subcutaneous angiolipomas.
Results: The patient underwent placement of a TAG stent graft to
cover the blood supply to his AVM, from the third intercostal artery to
immediately above the celiac artery. Additional coil embolization of the
T10 intercostal artery was chosen due to proximity of the celiac artery.
Completion angiography demonstrated signiﬁcant reduction in arterial
ﬂow to the AVM (Fig 2). On 1-year follow-up, the patient reported com-
plete relief of back pain and resolution of dyspnea on exertion.Fig 1. Sagittal view on computed tomography (A) demonstrates the
massive AVM (long arrow) involving the thoracic vertebrae and left hemi-
thorax. The dilated azygous system (arrows) is seen on coronal view (B).
>Eastern Vascular SocietyConclusions: Cobb syndrome is a rare and unusual disorder but
must be considered when patients present with vascular cutaneous mal-
formations and neurologic deﬁcits. Optimal treatment must be tailored
to the individual anatomy and pathophysiology and may require a com-
bination of endovascular techniques. This is the ﬁrst reported thoracic
endovascular stent graft repair of the descending aorta for a patient
with Cobb syndrome.
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Objectives: This study was conducted to determine the midterm re-
sults of hypogastric ﬂow preservation (HFP) during endovascular repair of
aortoiliac aneurysms.
Methods: This was a single institution review of patients with aortoil-
iac aneurysms treated with the intent for HFP using the snorkel technique.
Results: From June 2011 to December 2013, 32 aneurysms were
treated in 11 consecutive patients with bilateral aortoiliac (n ¼ 5), unilateral
aortoiliac (n ¼ 5), or isolated iliac aneurysms (n ¼ 1). In 10 cases a bifur-
cated main body device was used, followed by iliac limb snorkels. Adjunctive
embolization of a division of the right (n ¼ 2) or left (n ¼ 2) hypogastric,
with ﬂow preservation by ipsilateral stent graft placement in the remaining
division, was performed in three patients. Average time was 312 minutes,
ﬂuoroscopic time was 31.5 minutes, blood loss was 609 mL, and contrast
used was 111.5 mL. A total of 62 components were used (average, 5.6;
range, 3-7). Completion angiograms showed type II endoleaks in three pa-
tients, two of which resolved on the ﬁrst postoperative imaging study. The
single procedural failure (91% procedural success rate) occurred in the ﬁrst
patient treated with bilateral aneurysms; this was the only persistent type II
endoleak at 30 days. The 30-day primary patency rate was 100%. At a mean
follow-up of 12.1 months (range, 1-30 months), no patients had loss of
palpable pedal pulses, a decrease in ankle-brachial index, or buttock claudi-
cation I/L to snorkel for HFP.
Conclusions: The snorkel technique for HFP in patients with aortoil-
iac aneurysms provides excellent midterm aneurysm sac exclusion, limb
patency, and freedom from buttock claudication. Longer follow-up is
required to determine the durability of this technique.yNew England Society for Vascular Surgery
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Objectives: CEA in asymptomatic patients is recommended only
when postoperative complications and mortality are kept low; but predicting
CEA complications in a speciﬁc patient remains elusive. To better predict
30-day postoperative outcomes, we calculated a novel point-weight ordinal
Frailty Risk Score (FRS) by an analysis of 20 preoperative risk factors based
on their individual odds ratios (ORs) as predictors of postoperative compli-
cations using all vascular surgery cases in the 2005 to 2011 American
College of Surgeons National Surgical Quality Improvement Program
(ACS-NSQIP) database (n ¼ 121,015).
Methods: To compare the predictive value of this calculated FRS with
that of patient demographics and surgical variables alone, we examined the
predictive contribution value of ﬁve levels of FRS on four outcomes (stroke,
myocardial infarction [MI], and mortality), and a composite of the three
outcomes in all primary asymptomatic CEAs in the 2005 to 2011 ACS-
NSQIP database (n ¼ 39,859).
Results: Thirty-day mortality occurred in 273 patients (0.7%), stroke
in 527 (1.3%), MI in 301 (0.8%), and the composite outcome was positive
in 1008 (2.5%). We found that by itself, the FRS level was strongly and
signiﬁcantly associated with all four outcomes (Table). For stroke, we
used only three levels of frailty because the stroke rate no longer increased
after this point, and found that for the lowest vs highest frailty levels, the
rate of stroke was 1.1% vs 2.4% (P < .0001). Percentage of patients that
were positive for the composite outcome was 1.7% in lowest vs 15.2% in
the highest FRS group (P < .0001).
Conclusions: An easy-to-calculate FRS can help stratify risk based on
preoperative patient characteristics and will help to identify asymptomatic
patients for whom CEA is risky.Table. Percentage of patients positive for each outcome by frailty level
Frailty
level
Death, Stroke, MI, Composite outcome,
% (95% CI) % (95% CI) % (95% CI) % (95% CI)
1 0.2 (0.2-0.3) 0.2 (0.2-0.3) 0.4 (0.3-0.5) 1.7 (1.5-1.9)
2 0.7 (0.6-0.9) 1.3 (1.2-1.5) 0.8 (0.7-0.9) 2.6 (2.4-2.8)
3 1.6 (1.2-2.0) 2.4 (1.9-2.9) 1.7 (1.3-2.1) 5.1 (4.4-5.8)
4 3.0 (1.7-4.4) 1.6 (0.6-2.6) 2.2 (1.1-3.4) 6.4 (4.5. 8.3)
5 10.7 (5.0-16.4) 1.8 (0-4.2) 5.4 (1.2-9.5) 15.2 (8.5-21.8)
CI, Conﬁdence interval; MI, myocardial infarction.Disclosures: A. N. Sidawy: Nothing to disclose; R. F. Neville: Nothing to
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Objectives: Patients treated with endovascular abdominal aortic aneu-
rysm (AAA) repair (EVAR) require lifelong follow-up. Although a variety of
post-EVAR surveillance protocols have been suggested, adherence to
follow-up outside of industry-funded clinical trials has been challenging.
We aim to describe an effective system for EVAR surveillance over 10 years
that results in exceptional follow-up.
Methods: From 2003 to 2013, 225 EVARs were performed for elec-
tive, symptomatic, or ruptured AAA using a variety of commercially avail-
able devices at a single, rural, academic center. After repair, all patients>Eastern Vascular Society
yNew England Society for Vascular Surgerywere followed up every 6 to 12 months with clinic visits and imaging
(computed tomography or ultrasound). All patients were entered into the
Vascular Quality Initiative database, which was audited quarterly by hospital
quality personnel. At the time of the audit, a list of EVAR patients due for
imaging was generated and forwarded to a dedicated vascular clinic nurse
who arranged imaging and clinic visits for those missing follow-up. Mortal-
ity and rationale for incomplete follow-up were recorded in a prospective
follow-up database.
Results: In hospital mortality was 0.9% for elective or symptomatic
AAA and 25% for ruptured AAA. Most (99%) were discharged to home
and 98% remained independent at 1 year. All-cause mortality was 7.2%,
25.4%, 44.9%, and 68.1% at 1, 3, 5, and 10 years. Median follow-up was
3.7 years. Using the above protocol resulted in comprehensive follow-up of
patients at 1, 3, and 5 years of 96%, 92%, and 84%, respectively. A signiﬁcant
drop off in adherence to follow-up was noted at 9 years. Resources required
to accomplish this were minimal, with <0.05 nursing full-time equivalents
and <0.05 full-time equivalents for hospital quality personnel (Fig).
Conclusions: EVAR has acknowledged rates of short-term and long-
term failure so that implantation of the stent graft is only part of successful
treatment of AAA. The follow-up program we describe is comparable to
that achieved in industry-sponsored trials. With many groups currently
participating in the Vascular Quality Initiative, the methodology presented
here is reproducible.
Fig. Follow-up of endovascular abdominal aortic aneurysm (AAA) repair
(EVAR) patients.
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Venous Thromboembolism in High-Risk Patients: Are We Doing
Enough for Prevention?>
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Objectives: Hospital-acquired venous thromboembolism (VTE) is a
costly quality and safety indicator thought to be preventable. Embedding
risk-assessment models into the electronic medical record (EMR) to in-
crease appropriate use of VTE prophylaxis for low-risk, medium-risk, and
high-risk patients is one strategy to decrease VTE events. We proposed
that high-risk patients receiving prophylaxis with mechanical and pharmaco-
logic methods would have a lower VTE rate than those who received one
prophylactic modality or none.
Methods: All medical and surgical patients admitted from October 1,
2011, to October 31, 2012 were reviewed. The EMR was reviewed for the
VTE risk-assessment score determined upon admission, the type of VTE
prophylaxis used, and the rate of hospital-acquired VTE by risk category.
Results: Of the 24,960 patients admitted, 175 (0.71%) developed
VTE during their hospital stay. At the time of admission, 16.7% (4164)
were assigned to the high-risk group, of which 71.3% (2967) received me-
chanical and pharmacologic prophylaxis, 13.0% (542) mechanical alone,>Eastern Vascular Society
